ALAFI Capital Co. LLC is 10% Owner at Intra-Cellular Therapies, Inc. (ITCI). They have made 8 open-market trades across 2 companies since 2007, most recently 2017-10-02.
CIK 0001216017
8 open-market purchases totalling $6.0M since 2007, never a sale. Across 8 scored buys the stock is down 2.1% at ninety days, and 3.8 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 13% | 75% | 63% |
| Avg Move | -16.7% | -0.2% | -2.1% |
| Alpha | -12.5% | -0.8% | -3.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ITCI | BUY | 2017-10-02 | 2017-10-03 | $15.50 | $4.0M | +0.7% | -7.7% | -5.1% |
| ITCI | BUY | 2016-12-06 | 2016-12-07 | $16.27 | $1.1M | -6.3% | +0.2% | -17.9% |
| ITCI | BUY | 2014-12-01 | 2014-12-03 | $14.75 | $21K | -24.0% | +1.4% | +1.4% |
| ITCI | BUY | 2014-11-28 | 2014-11-28 | $14.75 | $516K | -24.0% | +1.4% | +1.4% |
| ITCI | BUY | 2014-11-19 | 2014-11-21 | $14.25 | $15K | -24.0% | +1.4% | +1.4% |
| ITCI | BUY | 2014-11-14 | 2014-11-18 | $14.26 | $52K | -24.0% | +1.4% | +1.4% |
| ITCI | BUY | 2014-11-11 | 2014-11-13 | $15.34 | $187K | -24.0% | +1.4% | +1.4% |
| STXS | BUY | 2007-03-15 | 2007-03-19 | $10.89 | $109K | -7.9% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.